Jazz Pharmaceuticals JAZZ Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Jazz Pharmaceuticals’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's interest coverage?
- Jazz Pharmaceuticals (JAZZ) reported interest coverage of -1.4× in Q3 2025.
- How has Jazz Pharmaceuticals's interest coverage changed year-over-year?
- Jazz Pharmaceuticals's interest coverage decreased by 179.1% year-over-year, from 1.8× to -1.4×.
- What is the long-term trend for Jazz Pharmaceuticals's interest coverage?
- Over 4 years (2020 to 2024), Jazz Pharmaceuticals's interest coverage has grown at a -38.4% compound annual growth rate (CAGR), from 15.8× to 2.3×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.